The MaxCyte STX uses scalable electroporation for high quality (co)transfection of a variety of cells. It has the largest repertoire of compatible cell lines, as well as historically difficult to transfect cells such as primary cells, Jurkat and CHO cells, allowing researchers the flexibility to use their cell system of choice for cellular screening and protein production. The MaxCyte STX produces high level transfection efficiencies and cell viability enabling quality performance of the transfected cells in downstream functional assays including GPCR and Ion Channel screening.

The MaxCyte® STX™ Scalable Transfection System is a highly versatile, benchtop transfection platform that enables rapid and consistent production of transfected cells for use in Protein Production, High Throughput Screening (HTS), High Content Screening (HCS), and other cell-based assays. The MaxCyte STX uses proprietary flow electroporation technology to transfect primary cells, cell lines, and stem cells with a variety of biomolecules including DNA, RNA, siRNA, proteins or other molecules of interest. Flow electroporation provides for high cell loading efficiency and viability with unmatched reproducibility. This single platform can be used for small scale transfection (5x105 cells in seconds) ideal for assay development as well as large scale, bulk transfections (1x1010 cells in 20-30 minutes) often required for screening and protein production. Transfected cells can be used in a wide range of assays immediately following electroporation. If more suitable to assay scheduling, transfected cells can also be aliquoted and cryopreserved for future use.

Use the MaxCyte STX to:
• transfect 1 x 1010 cells in <30 minutes
• transfect primary cells & difficult-to-transfect cell lines
• express GPCR and multi-subunit Ion Channels
• perform large-scale protein production
• eliminate stable cell lines & transfection reagents
• lower your screening costs with high productivity

This platform provides a cost effective solution that uniquely fulfills the demands of all early phase drug development activities. The MaxCyte STX can help you develop assays faster, and in more biologically relevant cell types, increasing the productivity of your laboratory while improving the quantity and quality of your drug candidates.